<code id='EB68243E9F'></code><style id='EB68243E9F'></style>
    • <acronym id='EB68243E9F'></acronym>
      <center id='EB68243E9F'><center id='EB68243E9F'><tfoot id='EB68243E9F'></tfoot></center><abbr id='EB68243E9F'><dir id='EB68243E9F'><tfoot id='EB68243E9F'></tfoot><noframes id='EB68243E9F'>

    • <optgroup id='EB68243E9F'><strike id='EB68243E9F'><sup id='EB68243E9F'></sup></strike><code id='EB68243E9F'></code></optgroup>
        1. <b id='EB68243E9F'><label id='EB68243E9F'><select id='EB68243E9F'><dt id='EB68243E9F'><span id='EB68243E9F'></span></dt></select></label></b><u id='EB68243E9F'></u>
          <i id='EB68243E9F'><strike id='EB68243E9F'><tt id='EB68243E9F'><pre id='EB68243E9F'></pre></tt></strike></i>

          Home / comprehensive / hotspot

          hotspot


          hotspot

          author:hotspot    Page View:87215
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In